Lutonix

Minneapolis, United States Founded: 2007 • Age: 19 yrs Acquired By CR Bard
Drug-coated balloon catheters are developed for vascular lesion treatments.
Request Access

About Lutonix

Lutonix is a company based in Minneapolis (United States) founded in 2007 by Lixiao Wang was acquired by CR Bard in December 2011.. Lutonix has raised $35 million across 3 funding rounds from investors including CR Bard, Versant Ventures and Delphi Ventures. Lutonix operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.

  • Headquarter Minneapolis, United States
  • Founders Lixiao Wang
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Lutonix Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $35 M (USD)

    in 3 rounds

  • Latest Funding Round
    $10 M (USD), Series B

    Dec 13, 2010

  • Investors
    CR Bard

    & 4 more

  • Employee Count
    Employee Count
  • Acquired by
    CR Bard

    (Dec 20, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lutonix

Lutonix has successfully raised a total of $35M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series B — $10.0M
  • First Round

    (01 Jun 2007)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2010 Amount Series B - Lutonix Valuation

investors

Oct, 2008 Amount Series B - Lutonix Valuation Versant Ventures
Jun, 2007 Amount Series A - Lutonix Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lutonix

Lutonix has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include CR Bard, Versant Ventures and Delphi Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
Founded Year Domain Location
Investments are made in life sciences firms across all stages.
Founded Year Domain Location
VC firm that focuses on early stage investments in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lutonix

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lutonix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lutonix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lutonix

Lutonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Devices for treating peripheral and coronary vascular disease are developed.
domain founded_year HQ Location
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
domain founded_year HQ Location
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
domain founded_year HQ Location
Smart devices for monitoring coronary artery disease are developed.
domain founded_year HQ Location
Embolization devices are developed using Shape Memory Polymer foams.
domain founded_year HQ Location
Developer a system for venous arterialization of the lower limbs
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lutonix

Frequently Asked Questions about Lutonix

When was Lutonix founded?

Lutonix was founded in 2007.

Where is Lutonix located?

Lutonix is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.

Is Lutonix a funded company?

Lutonix is a funded company, having raised a total of $35M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jun 01, 2007.

What does Lutonix do?

Lutonix was founded in 2007 in Minneapolis, United States, focusing on the medical device sector. Drug-coated balloon catheters are offered for treating peripheral and coronary artery lesions. Paclitaxel, an anti-proliferative agent, is delivered by the catheters to inhibit restenosis. The company was acquired by Bard in 2011, with operations centered on cardiovascular interventions.

Who are the top competitors of Lutonix?

Lutonix's top competitors include Contego Medical, Limflow and Shape Memory Medical.

Who are Lutonix's investors?

Lutonix has 5 investors. Key investors include CR Bard, Versant Ventures, Delphi Ventures, USVP, and RiverVest Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available